This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. Branded drugs, developed through extensive research and clinical trials, often enjoy patent protection for a limited period.
BigData in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of bigdata in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.
Cloud-Based Clinical Database Systems : Leveraging cloud technology to streamline data management and collaboration. Advanced Data Analytics : Utilizing bigdata and machine learning to derive data-driven perspectives from clinical trial data.
In 2025, pharmaceutical trends are redefining how brands connect with healthcare professionals (HCPs), patients, and stakeholders. With machine learning and bigdata analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns.
Pharmaceutical brands must adapt to this new modality and pivot their promotional efforts to ensure that they can leverage the Telehealth channel effectively. SAVE YOUR SEAT TODAY. Telehealth: Is It Here to Stay? Once considered a novelty, over the past 18 months, Telehealth has risen to a prominent position in the continuum of care.
Related: Nestlé Expands Use of Blockchain Technology to Its Coffee Brand. Other researchers are also testing bigdata algorithms to see how well they can predict food fraud. The stakes are high for producers of expensive foods, which are particularly vulnerable to fraud. Predicting Fraud.
Why This Matters for Pharma Big tech and start-ups will bring new partnership opportunities, potential for digital transformation, and an open innovation to tackle some of your brands’ biggest challenges. There is still vast potential to connect wearable data, remote monitoring, and virtual care to improve patient outcomes.
Listen to how pharmaceutical brands and clinicians are adapting to this new modality and are pivoting their promotional efforts to ensure that they can leverage the Telehealth channel effectively. Telehealth: Past. Once considered a novelty, over the past 18 months, Telehealth has risen to a prominent position in the continuum of care.
BigData: Data-driven insights guide targeted advertising and refine messaging for different audience segments. Integrating these technologies doesnt just make campaigns more effective; it elevates how brands connect with their audiences. How can technology enhance pharma marketing strategies?
But that approach has fallen short of delivering coherent and high-quality customer experiences due to internal competition between brands, franchises, business units, etc. Once we combine data-driven and human behavioural insights, we can really understand what we can do. Principle 3: In AI we trust. Flat but strong leadership.
Listen to how pharmaceutical brands and clinicians are adapting to this new modality and are pivoting their promotional efforts to ensure that they can leverage the Telehealth channel effectively. Telehealth: Past. Once considered a novelty, over the past 18 months, Telehealth has risen to a prominent position in the continuum of care.
The presentation shared findings from a case study using Lexical Analytics, revealing how bigdata and AI drive commercial success. . Results also showed that the most effective ways for pharma executives to reach patients in 2020 included social media, digital advertising, and email from brands to patients. __.
The name Zeneca was invented by a branding consultancy who had been instructed to find a name which was memorable, had no associations with other companies, nor was offensive in any language”. The profits from these products funded the development of new drugs, such as gastroesophageal treatment Losec and cardiovascular treatment Aptin.
The rise of bigdata analytics, artificial intelligence, and machine learning has revolutionized drug discovery, development, and marketing. Pharma executives must navigate these regulatory complexities while maintaining compliance to protect their brand reputation and foster trust with stakeholders.
This approach not only enhances brand visibility but also drives patient education and empowerment, encouraging individuals to take a more active role in their healthcare decisions. By collaborating with influencers, pharma companies can tap into new patient communities and engage them in meaningful conversations about health and wellness.
So I would expect we’re going to find the same type of welcoming environment, maybe even more so with the pharma marketing network brand behind us. I think, you know, when we sat down, we had that lunch and I said, you know the opportunity here for us to take over the mantle and keep the pharma guy brand going.
Bigdata analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.
Choosing high-quality equipment for conducting calibrations on instruments can augment the instrument efficiency, accuracy, safety, and overall performance and enhance the brand value of the companies performing the analysis, testing, or measurement.
Syntegra has also engaged with the Federal Drug Administration (FDA) to evaluate the role of synthetic data in regulatory decisions, for COVID-19 and beyond.
With the COVID-19 pandemic, there has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent” says Michael D.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content